Jiangxi Silk Technology Co., Ltd.

Silk Technology was founded in March 2016 with a registered capital of 4 million yuan and a total project investment of 50 million yuan. Its main business is new materials based on biological proteins and implantable medical devices. It uses patented technology to extract silk fibroin from natural silk, closely integrates with medical engineering, and produces silk protein biomaterials for application in high-tech, high-value-added fields such as biomedicine and medical devices, creating a series of products and providing complete solutions for implantable medical devices, becoming a technological innovator in controllable degradable biomaterials and a major supplier of advanced biological consumables. It has applied for more than 20 related patents, broken through international technical barriers, and possesses multiple pioneering achievements that can be widely applied in implantable medical device fields such as orthopedics, neurosurgery, and dentistry (with a global market of tens of billions of US dollars annually), directly promoting the upgrade of existing 1.0-generation implantable medical materials mainly based on titanium alloys and ceramics to 2.0-generation materials mainly based on biological proteins, achieving leapfrog development, breaking the monopoly of foreign enterprises in this field, and is expected to form a full industrial chain covering medical care, electronics, environmental protection, beauty, and healthcare.
The team has strong technical strength, with multidisciplinary research backgrounds in materials, biology, mechanics, electronics, and clinical medicine. Many members have overseas study and work experience, supported by professional equity legal advisors, capital operation executives, and product certification teams. The company's current main business is silk fibroin biomedical devices and materials. The project team originates from the team of Deputy Director Tao Hu at the Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, and holds an advantageous position in the field of silk fibroin implantable medical devices, with deep technical accumulation and intellectual property in internationally renowned journals and patents; in addition, the project team closely cooperates with hospitals such as Xijing Hospital affiliated with the Fourth Military Medical University, Huashan Hospital affiliated with Fudan University, and Ninth People's Hospital affiliated with Shanghai Jiao Tong University, especially in clinical trials and product application promotion.